Cargando…

Oral regimen for multi-drug-resistant TB can promote patient-centred and community-based treatment

Detalles Bibliográficos
Autores principales:	Saurabh, Suman, Bhardwaj, Pankaj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884300/ https://www.ncbi.nlm.nih.gov/pubmed/35280615 http://dx.doi.org/10.4103/jfmpc.jfmpc_2502_20

Ejemplares similares

Tuberculosis Preventive Treatment in India: A Much-Needed Push Towards Achieving TB Elimination
por: Saurabh, Suman, et al.
Publicado: (2021)

Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
por: Aggarwal, Anivita, et al.
Publicado: (2020)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
por: Singh, Pravin K., et al.
Publicado: (2019)

Community Centres
por: Harding, Patrick
Publicado: (1963)

Single dose cefazolin plus metronidazole versus existing multi-dose regimen for prophylaxis in caesarean section
por: Pore, Shraddha M., et al.
Publicado: (2012)

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
por: Muniyandi, Malaisamy, et al.
Publicado: (2023)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
por: Achar, Jay, et al.
Publicado: (2015)

Linezolid resistance in patients with drug-resistant TB
por: Vengurlekar, D., et al.
Publicado: (2023)

Why need for five anti-tubercular drugs in a child with CNS TB?
por: Bagalkot, Praveen S.
Publicado: (2012)

Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
por: Tiberi, Simon, et al.
Publicado: (2021)

Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB
por: Izudi, J., et al.
Publicado: (2022)

Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
por: Kadkhoda, Kamran, et al.
Publicado: (2023)

UNITE4TB: a new consortium for clinical drug and regimen development for TB
por: Boeree, M. J., et al.
Publicado: (2021)

Multidrug-Resistant TB as A Major Concern for Tuberculosis Control Programs
por: KHAZAEI, Salman, et al.
Publicado: (2016)

Lessons from Jonathan Mann: The Ten Commandments on Multidrug-Resistant TB
por: Kirby, Michael
Publicado: (2016)

Comment on: Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis
por: Panigrahi, Pradeep K, et al.
Publicado: (2022)

Human Rights, TB, Legislation, and Jurisprudence
por: Dingake, O. B. K.
Publicado: (2017)

Co-administration of treatment for drug-resistant TB and hepatitis C
por: Olaru, I. D., et al.
Publicado: (2023)

Response to comments on: Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis
por: Bari, Aafreen, et al.
Publicado: (2022)

Nosocomial outbreak of multi-resistant Streptococcus pneumoniae serotype 15A in a centre for chronic pulmonary diseases
por: Bastiaens, Guido J. H., et al.
Publicado: (2018)

Is intermittent short-course anti-TB regimen as efficient and safe as daily anti-TB regimen for treating childhood TB?
por: Bhaumik, Soumyadeep
Publicado: (2015)

Magnitude of malnutrition amongst hospitalized TB patients
por: Sarin, Rohit, et al.
Publicado: (2011)

Dual burden of COVID-19 and TB in Africa
por: Wada, Yusuf Hassan, et al.
Publicado: (2021)

Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study
por: Sanchez, Julia, et al.
Publicado: (2020)

Benefits of a national network of drug information centres: RELIS
por: Schjøtt, Jan
Publicado: (2016)

Modified drug regimen for ophthalmic anesthesia during COVID-19 pandemic: Revisiting pharmacological concepts
por: Gurnani, Bharat, et al.
Publicado: (2021)

Serial Assays of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in Subjects Exposed to Patients with Active Tuberculosis
por: Moon, Hee-Won, et al.
Publicado: (2020)

Patient Satisfaction Survey: Can Nonresponders be Ignored?
por: Garg, Pankaj K, et al.
Publicado: (2012)

Damaged Proseal™ LMA inflation line can be repaired
por: Kundra, Pankaj, et al.
Publicado: (2010)

Heterogenous Immune Response to TB is Not a False Negative
por: DiNardo, Andrew
Publicado: (2020)

TB and HIV surveillance amid COVID-19 pandemic
por: Sherafat, Alireza, et al.
Publicado: (2022)

Ponticelli regimen and nephrotic syndrome
por: Laxminarayana, S.
Publicado: (2009)

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications
por: Rich, M. L., et al.
Publicado: (2023)

Exploring the Impact of Public Health Measures in Prevention and Control of Oral Cancer
por: Shrivastava, Saurabh Ram Bihari Lal, et al.
Publicado: (2013)

SMILS: Single-site, multi-Incision, laparoscopic surgery, the way forward?
por: Misra, Saurabh
Publicado: (2011)

How can we Improve the Universal Uptake of HIV Testing Services? World Health Organization
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2016)

Traumatic paediatric neurosurgical emergencies during the COVID-19 pandemic: experience in a single regional paediatric major trauma centre
por: Andalib, Amin, et al.
Publicado: (2020)

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline
por: Kaniga, K., et al.
Publicado: (2022)

Clinical and imaging features of drug-susceptible and multidrug-resistant TB in Korean adults
por: Kim, S-H., et al.
Publicado: (2023)

TB appearance in chest radiography in Cambodian migrant workers in Bangkok
por: Joob, Beuy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ok9v2i74idej3mqr0anqhr3g1l